Evidence map›Paper›PMID 32027885›Full record

ArticleBiochemical pharmacology2020

Cardiovascular phenotype of mice lacking 3-mercaptopyruvate sulfurtransferase.

Maria Peleli, Sofia-Iris Bibli, Zhen Li, Athanasia Chatzianastasiou, Aimilia Varela, Antonia Katsouda, Sven Zukunft, Mariarosaria Bucci, Valentina Vellecco, Constantinos H Davos and 5 more

Open access · greenAbstract read
In one paragraph

Article in Biochemical pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Sulfide regulation and catabolism in health and disease.Signal transduction and targeted therapy · 2025
    Review
  5. Review
  6. Article
  7. Cystathionine γ-lyase-derived HActa pharmacologica Sinica · 2024
    Article
  8. Review
  9. Using mechanism-based combinations of HNaunyn-Schmiedeberg's archives of pharmacology · 2024
    Article
  10. HCells · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Mitochondrial HCirculation research · 2022
    Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 5 countries.

Maria PeleliClinical, Experimental Surgery and Translational Research Center, Biomedical Research Foundation of the Academy of Athens, Greece; Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Greece.
Sofia-Iris BibliInstitute for Vascular Signalling, Centre for Molecular Medicine, Goethe University, Frankfurt am Main, German Centre for Cardiovascular Research (DZHK) Partner Site Rhein-Main, Frankfurt am Main, Germany.
Zhen LiCardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA, USA.
Athanasia Chatzianastasiou"George P. Livanos and Marianthi Simou" Laboratories, First Department of Pulmonary and Critical Care Medicine, Evangelismos Hospital, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Aimilia VarelaClinical, Experimental Surgery and Translational Research Center, Biomedical Research Foundation of the Academy of Athens, Greece.
Antonia KatsoudaClinical, Experimental Surgery and Translational Research Center, Biomedical Research Foundation of the Academy of Athens, Greece.
Sven ZukunftInstitute for Vascular Signalling, Centre for Molecular Medicine, Goethe University, Frankfurt am Main, German Centre for Cardiovascular Research (DZHK) Partner Site Rhein-Main, Frankfurt am Main, Germany.
Mariarosaria BucciDepartment of Pharmacy, School of Medicine, University of Naples Federico II, Naples, Italy.
Valentina VelleccoDepartment of Pharmacy, School of Medicine, University of Naples Federico II, Naples, Italy.
Constantinos H DavosClinical, Experimental Surgery and Translational Research Center, Biomedical Research Foundation of the Academy of Athens, Greece.
Noriyuki NagaharaIsotope Research Center, Nippon Medical School, Tokyo, Japan.
Giuseppe CirinoDepartment of Pharmacy, School of Medicine, University of Naples Federico II, Naples, Italy.
Ingrid FlemingInstitute for Vascular Signalling, Centre for Molecular Medicine, Goethe University, Frankfurt am Main, German Centre for Cardiovascular Research (DZHK) Partner Site Rhein-Main, Frankfurt am Main, Germany.
David J LeferCardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA, USA.
Andreas PapapetropoulosClinical, Experimental Surgery and Translational Research Center, Biomedical Research Foundation of the Academy of Athens, Greece; Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Greece. Electronic address: apapapet@pharm.uoa.gr.
Academy of Athens · GRNational and Kapodistrian University of Athens · GRUniversity of Naples Federico II · ITGerman Centre for Cardiovascular Research · DELouisiana State University Health Sciences Center New Orleans · USGoethe University Frankfurt · DENippon Medical School · JP

Funding

Roles of Endothelial and Smooth Muscle KATP Channels in Myocardial Ischemic InjuryR01HL146514 · NHLBI · LSU HEALTH SCIENCES CENTER · PI COETZEE, WILLIAM A, LEFER, DAVID JOSEPH · 2020 to 2023
$3.0M
Cardioprotective Actions of Hydrogen SulfideR01HL092141 · NHLBI · LSU HEALTH SCIENCES CENTER · PI LEFER, DAVID JOSEPH · 2009 to 2013
$1.9M
Endogenous Hydrogen Sulfide Enzymes in Heart FailureR01HL146098 · NHLBI · LSU HEALTH SCIENCES CENTER · PI XIA, HUIJING · 2019 to 2022
$1.6M
Cardioprotective Role of HumaninR56HL137711 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LEFER, DAVID JOSEPH, MUZUMDAR, RADHIKA HIREN · 2018 to 2018
$674k
NHLBI NIH HHS R01 HL092141NHLBI NIH HHS R01 HL146098NHLBI NIH HHS R01 HL146514NHLBI NIH HHS R56 HL137711
6 · The paper itself

Abstract

rationaleHydrogen sulfide (H

results3-MST is the most abundant transcript in the mouse heart, compared to CSE and CBS. 3-MST was mainly localized in smooth muscle cells and cardiomyocytes, where it was present in both the mitochondria and the cytosol. Levels of serum and cardiac H

conclusionsOverall, genetic ablation of 3-MST impacts on the mouse cardiovascular system in an age-dependent manner. Loss of 3-MST exerts a cardioprotective role in young adult mice, while with aging it predisposes them to hypertension and cardiac hypertrophy.

Indexed as

AnimalsAntioxidantsCardiovascular SystemCystathionine beta-SynthaseCystathionine gamma-LyaseGene Expression Regulation, EnzymologicHydrogen SulfideMaleMice, Inbred C57BLMice, KnockoutMyocardial Reperfusion InjuryMyocytes, CardiacNitric OxidePhenotypeReactive Oxygen SpeciesSulfurtransferases3-mercaptopyruvate sulphurtransferaseAntioxidantsCystathionine beta-SynthaseCystathionine gamma-LyaseHydrogen SulfideNitric OxideReactive Oxygen SpeciesSulfurtransferases3-mercaptopyruvate transferase (3-MST)AgingBlood pressureMyocardial infarctionNitric Oxide (NO)Reactive Oxygen Species (ROS)

Identifiers

PMID32027885
PMCPMC7657663
OpenAlexW3005240679

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.